Brainstorm Cell Therapeutics Inc (BCLI)

0.545 +0.020 (+3.81%)
Closed USD Disclaimer
0.535 -0.010 (-1.890%)

Brainstorm Cell Therapeutics Inc Company Profile

Equity Type
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.
Contact Information
New York,10019 United States
201 488 0460
Top Executives
Jacob Ahron Frenkel 78 2007 Independent Chairman of the Board
Andrew Hill Card 73 2011 Member of Business Advisory Board
Rasheda Ali 0 2007 Member of Business Advisory Board
Irit Arbel 63 2004 Co-Founder & Independent Vice Chair of the Board
Jerold Chun 0 2018 Chairman of Scientific Advisory Board
Nir Naor 49 2023 Independent Director
Stanley H. Appel 90 0000 Member of Scientific Advisory Board
Menghisteab Bairu 62 2021 Independent Director
Amit Bar-Or 0 0000 Member of Scientific Advisory Board
Ralph Z. Kern 65 2017 Member of Scientific Advisory Board
Anthony J. Polverino 60 2018 Independent Director
Uri Yablonka 47 2014 Executive VP, Chief Business Officer, Secretary & Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.